Lipum AB (LIPUM)

Currency in SEK
15.30
+1.10(+7.75%)
Closed·
LIPUM Scorecard
Full Analysis
Suffers from weak gross profit margins
LIPUM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.5016.30
52 wk Range
10.9021.20
Key Statistics
Prev. Close
14.2
Open
14.5
Day's Range
14.5-16.3
52 wk Range
10.9-21.2
Volume
5.86K
Average Volume (3m)
4.03K
1-Year Change
21.43%
Book Value / Share
0.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIPUM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Lipum AB Company Profile

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthritis in particular. The company was incorporated in 2010 and is based in Umeå, Sweden.

Employees
5
Market
Sweden

Compare LIPUM to Peers and Sector

Metrics to compare
LIPUM
Peers
Sector
Relationship
P/E Ratio
−5.0x−11.3x−0.5x
PEG Ratio
−0.18−0.210.00
Price/Book
108.7x5.9x2.6x
Price / LTM Sales
-68.9x3.3x
Upside (Analyst Target)
56.9%102.3%43.4%
Fair Value Upside
Unlock18.3%7.1%Unlock

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-0.90 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

LIPUM Income Statement

FAQ

What Stock Exchange Does Lipum Trade On?

Lipum is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Lipum?

The stock symbol for Lipum is "LIPUM."

What Is the Lipum Market Cap?

As of today, Lipum market cap is 324.55M.

What Is Lipum's Earnings Per Share (TTM)?

The Lipum EPS (TTM) is -3.23.

When Is the Next Lipum Earnings Date?

Lipum will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is LIPUM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Lipum Stock Split?

Lipum has split 0 times.

How Many Employees Does Lipum Have?

Lipum has 5 employees.

What is the current trading status of Lipum (LIPUM)?

As of 10 Aug 2025, Lipum (LIPUM) is trading at a price of 15.30, with a previous close of 14.20. The stock has fluctuated within a day range of 14.50 to 16.30, while its 52-week range spans from 10.90 to 21.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.